|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386.
2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Australian Institute of Health and Welfare
2015. Australia's Welfare 2015. Australia's welfare series no. 12.
Cat. no. AUS 189. Canberra, 2015.
|
|
3
|
Lawler M, Selby P, Aapro MS and Duffy S:
Ageism in cancer care. BMJ. 348(g1614)2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hurria A, Dale W, Mooney M, Rowland JH,
Ballman KV, Cohen HJ, Muss HB, Schilsky RL, Ferrell B, Extermann M,
et al: Designing therapeutic clinical trials for older and frail
adults with cancer: U13 conference recommendations. J Clin Oncol.
32:2587–2594. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Greer JB and Hawkins AT: Non-operative
management of rectal cancer. Semin Colon Rectal Surg. 30:79–84.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Heald RJ and Ryall RD: Recurrence and
survival after total mesorectal excision for rectal cancer. Lancet.
1:1479–1482. 1986.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kapiteijn E, Putter H and van de Velde CJ:
Cooperative investigators of the Dutch ColoRectal Cancer Group.
Impact of the introduction and training of total mesorectal
excision on recurrence and survival in rectal cancer in The
Netherlands. Br J Surg. 89:1142–1149. 2002.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ahn T: What should be considered for local
excision in early rectal cancer? Ann Coloproctol. 35:155–157.
2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Althumairi AA and Gearhart SL: Local
excision for early rectal cancer: Transanal endoscopic microsurgery
and beyond. J Gastrointest Oncol. 6:296–306. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Sauer R, Liersch T, Merkel S, Fietkau R,
Hohenberger W, Hess C, Becker H, Raab HR, Villanueva MT, Witzigmann
H, et al: Preoperative versus postoperative chemoradiotherapy for
locally advanced rectal cancer: Results of the German
CAO/ARO/AIO-94 randomized phase III trial after a median follow-up
of 11 years. J Clin Oncol. 30:1926–1933. 2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wan JF, Zhu J, Li GC, Sun WJ and Zhang Z:
Implications for determining the optimal treatment for locally
advanced rectal cancer in elderly patients aged 75 years and older.
Oncotarget. 6:30377–30383. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Jung B, Pahlman L, Johansson R and Nilsson
E: Rectal cancer treatment and outcome in the elderly: An audit
based on the Swedish Rectal Cancer Registry 1995-2004. BMC Cancer.
9(68)2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chang GJ, Skibber JM, Feig BW and
Rodriguez-Bigas M: Are we undertreating rectal cancer in the
elderly? An epidemiologic study. Ann Surg. 246:215–221.
2007.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Thiels CA, Bergquist JR, Meyers AJ,
Johnson CL, Behm KT, Hayman AV, Habermann EB, Larson DW and Mathis
KL: Outcomes with multimodal therapy for elderly patients with
rectal cancer. Br J Surg. 103:e106–e114. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Shahir MA, Lemmens VE, van de Poll-Franse
LV, Voogd AC, Martijn H and Janssen-Heijnen ML: Elderly patients
with rectal cancer have a higher risk of treatment-related
complications and a poorer prognosis than younger patients: A
population-based study. Eur J Cancer. 42:3015–3021. 2006.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Margalit DN, Mamon HJ, Ancukiewicz M,
Kobayashi W, Ryan DP, Blaszkowsky LS, Clark J, Willett CG and Hong
TS: Tolerability of combined modality therapy for rectal cancer in
elderly patients aged 75 years and older. Int J Radiat Oncol Biol
Phys. 81:e735–e741. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Francois E, Azria D, Gourgou-Bourgade S,
Jarlier M, Martel-Laffay I, Hennequin C, Etienne PL, Vendrely V,
Seitz JF, Conroy T, et al: Results in the elderly with locally
advanced rectal cancer from the ACCOR12/PRODIGE 2 phase III trial:
Tolerance and efficacy. Radiother Oncol. 110:144–149.
2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Choi Y, Kim JH, Kim JW, Kim JW, Lee KW, Oh
HK, Kim DW, Kang SB, Song C and Kim JS: Preoperative
chemoradiotherapy for elderly patients with locally advanced rectal
cancer-a real-world outcome study. Jpn J Clin Oncol. 46:1108–1117.
2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Guimas V, Boustani J, Schipman B, Lescut
N, Puyraveau M, Bosset JF and Servagi-Vernat S: Preoperative
chemoradiotherapy for rectal cancer in patients aged 75 Years and
older: Acute toxicity, compliance with treatment, and early
results. Drugs Aging. 33:419–425. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Pasetto LM, Friso ML, Pucciarelli S, Basso
U, Falci C, Bortolami A, Toppan P, Agostini M, Rugge M, Serpentini
S, et al: Rectal cancer neoadjuvant treatment in elderly patients.
Anticancer Res. 26 (5B):3913–3923. 2006.PubMed/NCBI
|
|
21
|
Jiang DM, Raissouni S, Mercer J, Kumar A,
Goodwin R, Heng DY, Tang PA, Doll C, MacLean A, Powell E, et al:
Clinical outcomes of elderly patients receiving neoadjuvant
chemoradiation for locally advanced rectal cancer. Ann Oncol.
26:2102–2106. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tougeron D, Roullet B, Paillot B, Hamidou
H, Tourani JM, Bensadoun RJ, Michel P and Silvain C: Safety and
outcome of chemoradiotherapy in elderly patients with rectal
cancer: Results from two French tertiary centres. Dig Liver Dis.
44:350–354. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Dobie SA, Warren JL, Matthews B, Schwartz
D, Baldwin LM and Billingsley K: Survival benefits and trends in
use of adjuvant therapy among elderly stage II and III rectal
cancer patients in the general population. Cancer. 112:789–799.
2008.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Bohac GC, Guaqueta D, Cheng DM, Aschengrau
A and Hartshorn KL: Disparity in the use of combined modality
therapy for rectal cancer in the older adult. J Geriatr Oncol.
4:90–97. 2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The Eighth Edition AJCC cancer staging manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Berg M, Danielsen SA, Ahlquist T, Merok
MA, Agesen TH, Vatn MH, Mala T, Sjo OH, Bakka A, Moberg I, et al:
DNA sequence profiles of the colorectal cancer critical gene set
KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset. PLoS
One. 5(e13978)2010.PubMed/NCBI View Article : Google Scholar
|
